CARDIFF ONCOLOGY, INC. Gain (Loss) on Disposition of Assets
CARDIFF ONCOLOGY, INC. (CRDF) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-02-29
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was -$1.00K.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for the quarter ending 2022-06-30 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for the quarter ending 2022-03-31 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for fiscal 2023 was $0.00.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for fiscal 2022 was -$1.00K.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for fiscal 2021 was -$1.00K.
- CARDIFF ONCOLOGY, INC. gain (loss) on disposition of assets for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | -$1.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | -$1.00K 10-Q · filed 2022-11-03 | -$1.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.00K 10-Q · filed 2022-08-04 | -$1.00K derived: sum of 3 quarters · filed 2022-08-04 | -$1.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-05 | -$1.00K derived: sum of 2 quarters · filed 2022-05-05 | -$1.00K derived: sum of 3 quarters · filed 2022-05-05 | -$1.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-08-05 | $0.00 derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-05-06 | $0.00 derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | -$165.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$164.85K derived: sum of 2 quarters · filed 2020-02-27 | -$362.95K 10-K · filed 2020-02-27 | |
| 2018-09-30 | $609.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$197.49K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$198.10K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | -$426.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$426.95K derived: sum of 2 quarters · filed 2019-03-06 | -$455.05K 10-K · filed 2019-03-06 | |
| 2017-09-30 | -$102.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$28.20K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$28.10K 10-Q · filed 2018-08-03 | |||
| 2016-12-31 | -$577.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$577.31K derived: sum of 2 quarters · filed 2018-02-26 | -$577.31K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$4.56K 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $24.84K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |